Brought to you by 
Aerie Pharmaceuticals raises $21mm with Series A round
26 Oct 2012
Executive Summary
Aerie Pharmaceuticals (developing ophthalmic drugs; spun-out of Duke University Medical Center) has raised $21mm with its Series A financing, which was co-led by Alta Partners and Texas Pacific Group (TPG) Ventures.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Aerie Pharmaceuticals raises $21mm with Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice